WallStreetZenWallStreetZen

How to Buy Structure Therapeutics Stock

Structure Therapeutics Inc

Structure Therapeutics Inc. , a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs.

Structure Therapeutics stock last closed at $39.32, down 0.3% from the previous day, and has increased 60.49% in one year. It has overperformed other stocks in the Biotechnology industry by 0.82 percentage points. Structure Therapeutics stock is currently +80.45% from its 52-week low of $21.79, and -47.59% from its 52-week high of $75.02.

As of May 1, 2024, there are 139.79M shares of GPCR outstanding. The market value of GPCR is $1.83B. In the past 24 hours, 631,779 GPCR shares were traded.

How to Buy Structure Therapeutics Stock

Not sure how to invest in Structure Therapeutics stock? Here's how.
  1. Choose where to buy Structure Therapeutics stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you choose where to buy Structure Therapeutics stock.
  2. Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
  3. Fund your investment account: Choose your payment method and add your info.
  4. Analyze Structure Therapeutics stock: The Structure Therapeutics ticker symbol is GPCR. Is Structure Therapeutics stock a good investment? Should you buy shares of GPCR? How do GPCR's underlying business fundamentals look? Do top analysts think Structure Therapeutics is a good buy? Why has GPCR's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if GPCR is a good stock to buy).
  5. Place your GPCR buy order: Decide if you will purchase GPCR shares at the current market price or use a limit order to purchase GPCR shares at a specific price.
  6. Get key alerts regarding your GPCR position: Create a watchlist to key updates about your position in Structure Therapeutics shares.

Step 1: Choose where to buy Structure Therapeutics stock

You will need an online brokerage account in order to access the NASDAQ market and buy GPCR shares.

A brokerage account is an investment account that allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

In our opinion, eToro is the best brokerage. Here's why:

  • Invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
  • Access to world financial markets: From Technology to Energy, New York to Tokyo — you can fill your portfolio with stocks from the world's leading stock exchanges.
  • Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of shares by opening an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for your brokerage account

Now that you've picked the best brokerage, the next step is to fill out some personal details so you are able to invest in GPCR stock today.

How to Open a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal data to create a new trading account.
  1. Send your data by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your investment account

Now that you've created your account on the best stock market app for beginners, you need to deposit funds:

Check out the tutorial below for more details transferring funds into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Structure Therapeutics stock

After you have chosen the best place to buy Structure Therapeutics stock, it's important to research their stock before you invest, so you truly understand the risk as well as the upside.

Structure Therapeutics stock data

GPCR Price
$39.32
1w %
7.93%
1y %
60.49%
5y %
N/A
P/E
-16.18x
P/B
4.04x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$89.62M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$1.83B
Next Earnings
May 9, 2024
Next Dividend
N/A

Structure Therapeutics Overview

WallStreetZen was built to help part-time investors perform more in-depth fundamental analysis in less time.

You can see all of the due diligence checks on GPCR's stock page.

Is GPCR stock overvalued?

You can use many financial metrics, analyses, models, and charts to gauge GPCR's intrinsic value.

Using relative valuations ratios:

  • GPCR could be undervalued based on its P/B ratio of 4.04x, relative to Biotechnology industry P/B ratio of 6.02x

You can do additional valuation research on GPCR's stock here.

A look at GPCR Cashflows and Balance Sheet

Passed Health Checks:

  • There are more short-term assets than short-term liabilities on the GPCR balance sheet.
  • GPCR has a low debt to equity ratio of 0.06.
  • There are more short-term assets than long-term liabilities on the GPCR balance sheet.
  • GPCR has $467.32M in cash and short term investments. This is sufficient to cover its annual cash burn of $81.66M.
  • GPCR has cash burn of 81655000. It has enough cash and short-term investments to cover this for at least one year.

Do Wall Street analysts think it's a good time to buy GPCR stock

Out of 2 Wall Street analysts who monitor GPCR, the consensus analyst rating on GPCR is a Strong Buy

It's important to keep in mind that analyst forecasts are not recommendations, nor are they financial advice.

You can dig deeper into what analysts are saying on the Structure Therapeutics stock forecast page.

GPCR Technical Indicators

SMA10
1.17
SMA20
1.08
SMA50
1.12
SMA100
1.37
SMA200
1.27
MACD
0.08
MACD Signal
0.01
MACD Histogram
0.07
RSI
54.05
Stochastic %K
70.13
Stochastic %D
83.8
StochRSI %K
72.92
StochRSI %D
86.59

Are GPCR insiders buying or selling the stock?

In the past 12 months, insiders at GPCR have not bought or sold any shares.

Learn more about who owns GPCR shares here.

Does GPCR stock generate passive income?

No, Structure Therapeutics doesn't provide an income stream by paying out dividends.

What do other investors have to say about GPCR?

One of the reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Place your GPCR buy order

You have two main order types:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are mostly sufficient.
  • Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
    If you want to make sure you're buying or selling at a specific dollar amount limit, use a limit order.

Click the Open button and your broker will place the order.

If you need more info about buying stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Get key alerts regarding your GPCR position

Now that you own some GPCR stock, you'll want to stay up-to-date on your new investment.

Make a watchlist to keep track of your GPCR stock.

GPCR Feed

How to Buy Stock in Structure Therapeutics

To summarize, here are the 6 steps you need to take to buy Structure Therapeutics stock right now:

  1. Choose where to buy Structure Therapeutics stock
  2. Sign up for your brokerage account
  3. Fund your investment account
  4. Analyze Structure Therapeutics stock
  5. Place your GPCR buy order
  6. Get key alerts regarding your GPCR position

If you require a online brokerage, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to get notifications regarding your investment in Structure Therapeutics, add GPCR to your watchlist by clicking the button below.

NASDAQ: GPCR
$39.32-0.12 (-0.3%)
Updated May 1, 2024
Open eToro Account
NASDAQ: GPCR
$39.32-0.12 (-0.3%)
Updated May 1, 2024
Open eToro Account

FAQ

How much does it cost to buy one Structure Therapeutics share?

As of May 1, 2024, it costs $39.32 to buy one share of Structure Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.254 shares of GPCR.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Structure Therapeutics stock?

According to 2 Wall Street analysts who monitor Structure Therapeutics, their consensus recommendation is to buy Structure Therapeutics stock.

What is the best way to buy Structure Therapeutics stock?

One way to place an order for Structure Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.